adimin

Ra Capital Management buys $15 million in Lenz Therapeutics stock

Investors looking to track insider transactions may note the recent activity of RA Capital Management, L.P., a significant shareholder in Lenz Therapeutics, Inc. (NASDAQ:LENZ). On March 21, 2024, RA Capital Management, through different funds and accounts under its management, made substantial purchases of Lenz Therapeutics\' common stock. The transactions, which were all purchases, amounted to...

Read More